Federal Register #2026-15296

NIH Announces DMICC Meeting on Type 1 Diabetes and Cardiorenal Outcomes

This notice announces a meeting organized by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), for the Diabetes Mellitus Interagency Coordinating Committee (DMICC). - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - Purpose of Meeting: - Focus on Type 1 Diabetes and cardiorenal outcomes - Aim to inform a practice-changing clinical trial - Participation Details: - Hybrid format: in-person and virtual attendance options - Stakeholders invited to provide oral or written comments - Procurement Details: - No products or services are being requested or procured - No OEMs, vendors, part numbers, or purchase quantities mentioned - Notable Requirements: - Strictly informational; not a solicitation or award opportunity

Description

The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on September 18th, 2026, focusing on "Type 1 Diabetes and Cardiorenal Outcomes: Informing a Practice Changing Trial." The meeting will be hybrid, held at The Hyatt Regency in Bethesda, MD, and virtually via Zoom. The DMICC facilitates cooperation and collaboration on diabetes-related activities among government entities. The meeting provides an opportunity for stakeholders to participate, present oral comments, and discuss current and future diabetes programs.

View original listing